Literature DB >> 7805734

IgG isotype distribution of local and systemic immune responses induced by influenza virus infection.

G Fazekas1, B Rosenwirth, P Dukor, J Gergely, E Rajnavölgyi.   

Abstract

The IgG isotype profile of the influenza virus-specific immune response was studied by quantitation of serum antibody (Ab) levels in correlation with the enumeration of antibody-secreting cells (ASC) detected in the lung, spleen, mediastinal lymph nodes (MLN), Peyer's patches and bone marrow (BM). Distinct isotypic patterns for serum Ab and Ab produced by cells present at or close to the site of infection were found after primary or repeated infections. An elevated number of IgM ASC was found after primary challenge in the spleen, lung and MLN. In contrast, the site of IgA and IgG production is restricted to the lung and lymph nodes draining the site of infection. In these organs IgA, IgG2a and IgG1 ASC are found as a result of primary virus infection while viral challenge induces mostly activation of IgA-producing cells and secretion of IgA to the lung lavage. In contrast, the majority (80-90%) of Ab detected in the serum belong to the IgG2a subclass and their serum level is maintained at a high level during the whole period of the response. The relative level of virus-specific serum IgG2a in correlation with the production of IgG2a Ab found predominantly in MLN and lung is highly dependent on the viral dose used for priming or challenge. As IgG2a ASC can be detected at relatively low numbers in the spleen and BM these results suggest that the production of the dominant IgG2a isotype of serum Ab occurs close to the viral challenge site. These data, however, point to distinct isotypic regulation in systemic versus local virus-specific Ab responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805734     DOI: 10.1002/eji.1830241222

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  An adjuvant for the induction of potent, protective humoral responses to an H5N1 influenza virus vaccine with antigen-sparing effect in mice.

Authors:  Yuk-Fai Lau; Lay-Hoon Tang; Amber W McCall; Eng-Eong Ooi; Kanta Subbarao
Journal:  J Virol       Date:  2010-06-10       Impact factor: 5.103

2.  Protective immunity against H5N1 influenza virus by a single dose vaccination with virus-like particles.

Authors:  Jae-Min Song; Jaber Hossain; Dae-Goon Yoo; Aleksandr S Lipatov; C Todd Davis; Fu-Shi Quan; Li-Mei Chen; Robert J Hogan; Ruben O Donis; Richard W Compans; Sang-Moo Kang
Journal:  Virology       Date:  2010-06-26       Impact factor: 3.616

3.  Genetically engineered live attenuated influenza A virus vaccine candidates.

Authors:  N T Parkin; P Chiu; K Coelingh
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

4.  Intranasal antigen targeting to MHC class II molecules primes local IgA and serum IgG antibody responses in mice.

Authors:  D P Snider; B J Underdown; M R McDermott
Journal:  Immunology       Date:  1997-03       Impact factor: 7.397

5.  Roles of CD4+ T-cell-independent and -dependent antibody responses in the control of influenza virus infection: evidence for noncognate CD4+ T-cell activities that enhance the therapeutic activity of antiviral antibodies.

Authors:  Krystyna Mozdzanowska; Michelle Furchner; Darya Zharikova; Jingqi Feng; Walter Gerhard
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  The B-cell response in lymphoid tissue of mice immunized with various antigenic forms of the influenza virus hemagglutinin.

Authors:  D M Justewicz; P C Doherty; R G Webster
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo.

Authors:  Maaike Stoel; Judith Pool; Jacqueline de Vries-Idema; Fatiha Zaaraoui-Boutahar; Maarten Bijl; Arno C Andeweg; Jan Wilschut; Anke Huckriede
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

8.  Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin.

Authors:  Fu-Shi Quan; Yeu-Chun Kim; Dae-Goon Yoo; Richard W Compans; Mark R Prausnitz; Sang-Moo Kang
Journal:  PLoS One       Date:  2009-09-25       Impact factor: 3.240

9.  The Transcription Factor T-bet Resolves Memory B Cell Subsets with Distinct Tissue Distributions and Antibody Specificities in Mice and Humans.

Authors:  John L Johnson; Rebecca L Rosenthal; James J Knox; Arpita Myles; Martin S Naradikian; Joanna Madej; Mariya Kostiv; Aaron M Rosenfeld; Wenzhao Meng; Shannon R Christensen; Scott E Hensley; Jonathan Yewdell; David H Canaday; Jinfang Zhu; Adrian B McDermott; Yoav Dori; Max Itkin; E John Wherry; Norbert Pardi; Drew Weissman; Ali Naji; Eline T Luning Prak; Michael R Betts; Michael P Cancro
Journal:  Immunity       Date:  2020-04-29       Impact factor: 31.745

10.  Pulmonary infection with influenza A virus induces site-specific germinal center and T follicular helper cell responses.

Authors:  Alexander W Boyden; Kevin L Legge; Thomas J Waldschmidt
Journal:  PLoS One       Date:  2012-07-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.